CV Sciences Inc (CVSI, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. CV Sciences Inc is a life science company. It operates two business segments specialty pharmaceutical and consumer product. CV Sciences Inc has a market cap of $61.640 million; its shares were traded at around $0.62 with and P/S ratio of 1.19. GuruFocus has detected 2 severe warning signs with CV Sciences Inc. .
For the last quarter CV Sciences Inc reported a revenue of $9.33 million, compared with the revenue of $14.22 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $53.7 million, an increase of 11.3% from last year. For the complete 30-year financial data, please go here.. For the last five years CV Sciences Inc had an average revenue growth rate of 45.9% a year.
The reported loss per diluted share was 17 cents for the year, compared with the earnings per share of $-0.06 in the previous year. The CV Sciences Inc had an operating margin of -32.11%, compared with the operating margin of 21.24% a year before. The 10-year historical median operating margin of CV Sciences Inc is -62.49%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, CV Sciences Inc has the cash and cash equivalents of $9.11 million, compared with $12.7 million in the previous year. The long term debt was $9.52 million. CV Sciences Inc has a financial strength rank of 5 (out of 10).
For the complete 20-year historical financial data of CVSI, click here.
